- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
JHS Svendgaard's board approved reallocating 29.99 Cr from its preferential issue. Funds shift from specific equipment/group infusion to broader Capital Expenditure & Business Expansion (11.75 Cr) and Strategic & Growth Initiatives (10.75 Cr), alongside General Corporate (7.50 Cr), for enhanced flexibility.